Tianyin Pharmaceutical (TPI) Q2 EPS Drops to $0.06

Tianyin Pharmaceutical (NYSE: TPI) reported Q2 EPS of $0.06, versus $0.20 reported last year. Revenue for the quarter came in at $18.2 million, versus $25.3 million reported last year.

For earnings history and earnings-related data on Tianyin Pharmaceutical (TPI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c